FDA Issues Warning on General Anesthetics, Sedative Use in C
The FDA released a warning on Dec. 15 about the use of general anesthetics and sedatives in children under 3 years old and pregnant women during their third trimester. Repeated or continuing use may harm brain development in children, according to the agency.

The FDA will now require warnings about this risk to be added to the labels of the following general anesthetic and sedation drugs:
• desflurane (Suprane)
• etomidate (Amidate)
• halothane
• isoflurane (Forane)
• ketamine (Ketalar)
• lorazepam injection (Ativan)
• methohexital (Brevital)
• midazolam injection, syrup
• pentobarbital (Nembutal)
• propofol (Diprivan)
• sevoflurane (Ultane, Sojourn)

Read More:
http://www.anesthesiologynews.com/Web-Only/Article/12-16/FDA-Issues-Warning-on-General-Anesthetics-Sedative-Use-in-Children/38905
Like
Comment
Share